Padlock Therapeutics Director of Business Development Salaries in Boulder
The average Padlock Therapeutics Director of Business Development in Boulder earns an estimated $209,279 annually, which includes an estimated base salary of $159,531 with a $49,747 bonus. Padlock Therapeutics' Director of Business Development compensation is $42,976 more than the US average for a Director of Business Development. Director of Business Development salaries at Padlock Therapeutics in Boulder can range from $73,000 - $390,000.
In Boulder, The Business Development Department at Padlock Therapeutics earns $15,988 more on average than the Customer Support Department.
Last updated 5 years ago.
- $159,531
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Padlock Therapeutics
In Boulder, Directors of Business Development earn $3,261 more than Directors of Business Development.
Compensation at Padlock Therapeutics by Department
In Boulder, The Business Development Department averages $15,988 more than the Customer Support Department, and $7,112 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Padlock Therapeutics reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Padlock Therapeutics reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Padlock Therapeutics Rate Their Compensation
The majority of Directors of Business Development at Padlock Therapeutics believe they're compensated fairly. 50% of Directors of Business Development at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics
